The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy
Abstract
Serum creatine-kinase (CK) activities were determined in 536 patients affected with X-linked muscular dystrophy (456 with Duchenne or DMD and 80 with Becker or BMD) and serum pyruvate-kinase (PK) in 360 among them (309 DMD and 51 BMD). The aim of this investigation was to assess the variability and rate of decrease in serum activity in DMD as compared with BMD as a function of age and in DMD as a function of Vignos scale as well. In DMD, maximum CK and PK activities were found around 1-6 years old and the average rate of decline according to age was estimated as 0.18 per year and 0.27-0.29 for both enzymes as a function of Vignos scale (assessed in 291 cases). For BMD, maximum serum enzyme levels were found around 10-15 years old and the rate of decline of serum activity per year was 0.06 for CK and 0.07 for PK. If maximum levels of serum enzyme reflect active muscle degeneration and the rate of decline per year to progressive loss of muscle mass (responsible for the release of muscle enzymes to the blood stream) our observations suggest: (a) active muscle degeneration occurs, on average, 5 years later in the group of outliers and 10 years later in BMD as compared with severe DMD; (b) the rate in which muscle mass is lost is significantly greater in DMD than in BMD and therefore serum enzyme determinations may represent an important test for evaluation of therapeutic trials; (c) serum enzymes determination may represent an important preliminary test to discriminate in a proportion of young patients if they will develop a severe or milder phenotype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“8 week old mdx/mTRG2 males already have remarkably elevated serum CK (7,594±928 IU/L), compared to mdx/mTRHet males (1,148±477 IU/L)(Fig. 1B), approximating human DMD levels (6,000–8,000 IU/L in 10 year old patients)(Zatz et al., 1991).”
From Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice (2010) · cites this paper as Zatz et al., 1991
In the citing paper
“However, by 60 weeks of age, CK levels decline in mdx/mTRG2 mice (Fig. S1A), consistent with CK levels in DMD patients which peak at 1–6 years of age when active muscle degeneration is occurring, and then decrease with age, as muscle tissue is progressively lost (Zatz et al., 1991).”
From Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice (2010) · cites this paper as Zatz et al., 1991
Citations
Cites
Baltosser, W. H., & Zar, J. H. (1996) · Ecology · doi:10.2307/2265725 · Cited by 35,166
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693
Koenig, M., Beggs, A. H., Moyer, M., Scherpf, S., Heindrich, K., Bettecken, T., Meng, G., Müller, C. R., Lindlöf, M., Kääriäinen, H. A., et al. (1989) · Europe PMC (PubMed Central) · Cited by 1,113
Hoffman, E. P., Fischbeck, K. H., Brown, R. H., Johnson, M., Medori, R., Loire, J. D., Harris, J. B., Waterston, R., Brooke, M., Specht, L., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805263182104 · Cited by 927
Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts
Partridge, T. A., Morgan, J. E., Coulton, G. R., Hoffman, E. P., & Kunkel, L. M. (1989) · Nature · doi:10.1038/337176a0 · Cited by 878
(1965) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1965.tb71746.x · Cited by 585
Brooke, M. H., Fenichel, G. M., Griggs, R. C., Mendell, J. R., Moxley, R., Miller, J. P., & Province, M. A. (1983) · Muscle & Nerve · doi:10.1002/mus.880060204 · Cited by 353
Quantitation of muscle function in children: A prospective study in duchenne muscular dystrophy
Scott, O. M., Hyde, S. A., Goddard, C., & Dubowitz, V. (1982) · Muscle & Nerve · doi:10.1002/mus.880050405 · Cited by 298
Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies
Baumbach, L. L., Chamberlain, J. S., Ward, P. A., Farwell, N. J., & Caskey, C. T. (1989) · Neurology · doi:10.1212/wnl.39.4.465 · Cited by 192
Further studies of gene deletions that cause Duchenne and Becker muscular dystrophies
Forrest, S. M., Cross, G. S., Flint, T., Speer, A., Robson, K. J. H., & Davies, K. E. (1988) · Genomics · doi:10.1016/0888-7543(88)90091-2 · Cited by 175
Research works printed but not linked: 1
- Wu, 1988, Evidence for abnormal growth hormone (GH) in a boy with Duchenne muscular dystrophy (DMD) and growth failure, Pediatr. Res., 23, 560A
Cited by
Cellular and Molecular Regulation of Muscle Regeneration
CHARGÉ, S. B. P., & RUDNICKI, M. A. (2004) · Physiological Reviews · doi:10.1152/physrev.00019.2003 · Cited by 2,680
Creatine kinase monitoring in sport medicine
Brancaccio, P., Maffulli, N., & Limongelli, F. M. (2007) · British Medical Bulletin · doi:10.1093/bmb/ldm014 · Cited by 937
Biochemical markers of muscular damage
Brancaccio, P., Lippi, G., & Maffulli, N. (2010) · cclm · doi:10.1515/cclm.2010.179 · Cited by 839
Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice
Sacco, A., Mourkioti, F., Tran, R., Choi, J., Llewellyn, M., Kraft, P., Shkreli, M., Delp, S., Pomerantz, J. H., Artandi, S. E., et al. (2010) · Cell · doi:10.1016/j.cell.2010.11.039 · Cited by 512
Allen, D. G., Whitehead, N. P., & Froehner, S. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00007.2015 · Cited by 426
Metadata
- Authors
- Zatz, M., Rapaport, D., Vainzof, M., Passos-Bueno, M. R., Bortolini, E. R., Pavanello, R. D. C. M., & Peres, C. A.
- Affiliations
- Universidade de São Paulo (BR)
- Universidade Federal do Espírito Santo (BR)
- Corresponding author
- Zatz, Mayana
- Venue
- Journal of the Neurological Sciences
- Publisher
- Elsevier BV
- Published
- 1991-04
- Volume
- 102
- Issue
- 2
- Pages
- 190-196
- ISSN
- 0022-510X (ISSN-L)
- OpenAlex
- W2045209184
- Cited by
- 159
- References
- 35
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 9 · 2023: 7 · 2022: 7 · 2021: 4 · 2020: 12 · 2019: 7 · 2018: 10 · 2017: 8 · 2016: 8 · 2015: 17 · 2014: 12 · 2013: 4 · 2012: 2
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of the Neurological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Surgery › Muscle and Compartmental Disorders
- Keywords
- Duchenne muscular dystrophy, Becker muscular dystrophy, serum creatine kinase, X-linked muscular dystrophy, muscle degeneration, muscle mass loss, age-related enzyme decline
- MeSH terms
- Adolescent, Adult, Age Factors, Child, Child, Preschool, Creatine Kinase, Humans, Infant, Muscular Dystrophies, Predictive Value of Tests, Pyruvate Kinase, Regression Analysis, Severity of Illness Index, Dystrophin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy. https://app.cochat.ai/papers/10.1016/0022-510x(91)90068-i
- The paper
- Zatz, M., Rapaport, D., Vainzof, M., Passos-Bueno, M. R., Bortolini, E. R., Pavanello, R. D. C. M., & Peres, C. A. (1991). Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy. Journal of the Neurological Sciences. https://doi.org/10.1016/0022-510x(91)90068-i
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.